Search clinical trials for: donors who received and in those who did not receive filgrastim.

Total 492830 results

Center for International Blood and Marrow Transplant...
National Marrow Donor Program

Completed

National Marrow Donor Program Long-Term Donor Follow-Up (LTDFU)

Hematologic Neoplasms

United States, Puerto Rico
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Neutropenia (Low White Blood Cell Count)

United States
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Neutropenia (Low White Blood Cell Count)

United States
Chang Gung Memorial Hospital

Recruiting

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

Neutropenia | Pediatric Cancer | G-CSF | Lenograstim | Filgrastim

Taiwan
Ottawa Hospital Research Institute

Active, not recruiting

A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy

Early-stage Breast Cancer

Canada
Noha Mansour

Not yet recruiting

Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients

Breast Cancer | Filgrastim Adverse Reaction
Alberta Health services

Completed

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

Peripheral Stem Cell/Marrow Transplant

Canada
Cancer Institute and Hospital, Chinese Academy...
Zhejiang Cancer Hospital; Changhai Hospital; Fudan University; Fujian Cancer Hospital and other collaborators

Completed

A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy

Cancer
Franziska Wachter
Harvard Clinical and Translational Science Center (Harvard Catalyst)

Recruiting

A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies (MORE)

Acute Myeloid Leukemia | Myelodysplastic Syndromes | MDS | Aml | Myeloid Neoplasm | Myeloid Malignancies | Inherited Bone Marrow Failure Syndrome

United States
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.

Non-metastatic Breast Cancer

Hungary, Spain
Xiamen Amoytop Biotech Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients (Filgrastim)

Chemotherapy Patients

China
National Cancer Institute (NCI)

Completed

Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy

Rhabdomyosarcoma | Synovial Sarcoma | Ewing's Sarcoma | MPNST | High-risk Sarcoma

United States
South Valley University

Completed

Filgrastim for Premature Ovarian Insufficiency (FIL-POI)

Premature Ovarian Failure
Ottawa Hospital Research Institute

Unknown

Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery (GIST)

Ischemic Stroke

Canada
National Institutes of Health Clinical Center (CC)

Completed

Pharmacokinetics of Granulocyte Colony Stimulating Factor in the Breast Milk of Volunteer Peripheral Blood Stem Cell Donor

Normal Physiology

United States
Ottawa Hospital Research Institute

Recruiting

Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy (REaCT-OGF)

Early-stage Breast Cancer

Canada
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Solid Tumors | Malignant Hemopathy | Chemotherapy-induced Febrile Neutropenia (FN)

France
Biocad

Completed

Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

Leucocytosis
Center for International Blood and Marrow Transplant...
National Marrow Donor Program

Recruiting

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

Healthy

United States
Memorial Sloan Kettering Cancer Center
Amgen

Completed

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Breast Cancer

United States
Sandoz
Sandoz GmbH

Terminated

Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia

Severe Chronic Neutropenia

Germany, Sweden
University of Florence

Completed

Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage

Habitual Abortion

Italy
Armando Santoro, MD

Completed

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Tumors | Hematological Neoplasms

Italy
University of California, San Francisco

Completed

Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors

Healthy

United States
National Cancer Institute (NCI)

Terminated

Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma

Multiple Myeloma | Leukemia, Plasma Cell

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia

Lymphoma | Leukemia

United States
Masonic Cancer Center, University of Minnesota

Terminated

Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia

Leukemia

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer

Breast Cancer

United States
Buddhist Tzu Chi General Hospital

Terminated

Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease

Parkinson Disease

Taiwan
National Institute of Allergy and Infectious Diseases...

Completed

A Study of Stem Cells and Filgrastim

HIV Infections

United States
University Hospital, Brest

Completed

Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure (ZAPA)

Multiple Myeloma | Hodgkin Lymphoma | Non-hodgkin Lymphoma
Aaron Cumpston, PharmD, BCOP

Completed

Effect of Body Mass on Filgrastim Pharmacokinetics

Neutropenia | Hematological Malignancy

United States
Hospices Civils de Lyon

Recruiting

Severe Bullous Drug Eruption and Filgrastim (GNET)

Rare Diseases | Toxic Epidermal Necrolyses

France
University of South Florida

Completed

Efficacy and Safety of Filgrastim in Alzheimer's Disease (FFAD)

Alzheimer's Disease

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma

Metastatic Colorectal Adenocarcinoma

United States, Netherlands
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes

Myelodysplastic Syndromes | Anemia

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Collection of Bone Marrow From Donors Treated With or Without Filgrastim

No Evidence of Disease | Healthy Stem Cell Donor

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation

Plasma Cell Myeloma

United States
Andrews Research & Education Foundation
Florida

Recruiting

Comparison of Quality and Quantity of M-PRP Cellular Content Filgrastim vs. Pegfilgrastim (M-PRP)

Healthy

United States
Trio Fertility

Recruiting

The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency

Primary Ovarian Insufficiency | Premature Ovarian Failure

Canada
Ottawa Hospital Research Institute

Completed

A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia (REaCT-G2)

Early Stage Breast Cancer

Canada
Megalabs

Not yet recruiting

Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers

Healthy
Medical University of Bialystok

Unknown

Efficacy Safety of Granulocyte Colony-stimulating Factor Treatment Children and Adolescents With Muscular Dystrophy

Increase Muscle Strength in Patients With Muscular Dystrophy

Poland
M.D. Anderson Cancer Center
Amgen

Terminated

Tissue Repair in Stem Cell Transplant Recipients

Graft-Versus-Host Disease

United States
Gema Biotech S.A.
QUID Quality in Drugs and Devices Latin American Consulting SRL

Unknown

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Breast Cancer

Argentina
Seoul St. Mary's Hospital

Unknown

Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML (DeGREE)

Leukemia, Myeloid, Acute

Korea, Republic of
Schwartzberg, Lee, M.D.
Amgen

Completed

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

Non-small Cell Lung Cancer

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Non-Hodgkin's Lymphoma | Plasma Cell Myeloma

United States
Pfizer

Completed

A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product.

Healthy Volunteers

United States
Hospital Infantil Universitario Niño Jesús, Madrid...
Universitat Autonoma de Barcelona; Instituto de Investigación Sanitaria de... and other collaborators

Completed

Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A (FANCOLEN-1)

Fanconi Anemia

Spain

3

Subscribe